Literature DB >> 26699195

Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2.

Nishi R Sharma1, Xiaohong Wang1, Vladimir Majerciak1, Masahiko Ajiro1, Michael Kruhlak2, Craig Meyers3, Zhi-Ming Zheng4.   

Abstract

Argonaute-2 protein (Ago2), a major component of RNA-induced silencing complex (RISC), has been viewed as a cytoplasmic protein. In this study, we demonstrated by immunofluorescence confocal microscopy that Ago2 is distributed mainly as a nuclear protein in primary human foreskin keratinocytes in monolayer cultures and their derived organotypic (raft) cultures, although it exhibits only a minimal level of nuclear distribution in continuous cell lines such as HeLa and HaCaT cells. Oncogenic human papillomavirus type 16 (HPV16) or type 18 (HPV18) infection of the keratinocytes does not affect the nuclear Ago2 distribution. Examination of human tissues reveals that Ago2 exhibits primarily as a nuclear protein in skin, normal cervix, and cervical cancer tissues, but not in larynx. Together, our data provide the first convincing evidence that the subcellular distribution of Ago2 occurs in a cell type- and tissue context-dependent manner and may correlate with its various functions in regulation of gene expression.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Ago2; RNA-binding protein; cervix; keratinocyte; keratinocytes; microRNA (miRNA); microscopic imaging; nuclear distribution; papillomavirus; virus

Mesh:

Substances:

Year:  2015        PMID: 26699195      PMCID: PMC4732213          DOI: 10.1074/jbc.C115.695049

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules.

Authors:  Anthony K L Leung; J Mauro Calabrese; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 2.  Argonaute proteins: key players in RNA silencing.

Authors:  Gyorgy Hutvagner; Martin J Simard
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

3.  Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression.

Authors:  Jeong-Gu Kang; Natalia Pripuzova; Vladimir Majerciak; Michael Kruhlak; Shu-Yun Le; Zhi-Ming Zheng
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

4.  Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression.

Authors:  Vladimir Majerciak; Michael Kruhlak; Pradeep K Dagur; J Philip McCoy; Zhi-Ming Zheng
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

5.  The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation.

Authors:  Shuang Tang; Mingfang Tao; J Philip McCoy; Zhi-Ming Zheng
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter.

Authors:  Yongjun Chu; Xuan Yue; Scott T Younger; Bethany A Janowski; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-07-30       Impact factor: 16.971

Review 7.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

8.  Importin 8 regulates the transport of mature microRNAs into the cell nucleus.

Authors:  Yao Wei; Limin Li; Dong Wang; Chen-Yu Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2014-03-04       Impact factor: 5.157

9.  Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs.

Authors:  Lasse Weinmann; Julia Höck; Tomi Ivacevic; Thomas Ohrt; Jörg Mütze; Petra Schwille; Elisabeth Kremmer; Vladimir Benes; Henning Urlaub; Gunter Meister
Journal:  Cell       Date:  2009-01-22       Impact factor: 41.582

10.  Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6.

Authors:  Xiaohong Wang; Hsu-Kun Wang; J Philip McCoy; Nilam S Banerjee; Janet S Rader; Thomas R Broker; Craig Meyers; Louise T Chow; Zhi-Ming Zheng
Journal:  RNA       Date:  2009-03-03       Impact factor: 4.942

View more
  14 in total

1.  KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182.

Authors:  Nishi R Sharma; Vladimir Majerciak; Michael J Kruhlak; Lulu Yu; Jeong Gu Kang; Acong Yang; Shuo Gu; Marvin J Fritzler; Zhi-Ming Zheng
Journal:  Nucleic Acids Res       Date:  2019-09-26       Impact factor: 16.971

2.  Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.

Authors:  Masahiko Ajiro; Shuang Tang; John Doorbar; Zhi-Ming Zheng
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

3.  The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues.

Authors:  Xiang-Yang Xue; Vladimir Majerciak; Aayushi Uberoi; Bong-Hyun Kim; Deanna Gotte; Xiongfong Chen; Maggie Cam; Paul F Lambert; Zhi-Ming Zheng
Journal:  PLoS Pathog       Date:  2017-11-27       Impact factor: 6.823

4.  microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus.

Authors:  Sunantha Sethuraman; Lauren Appleby Gay; Vaibhav Jain; Irina Haecker; Rolf Renne
Journal:  PLoS Pathog       Date:  2017-07-17       Impact factor: 6.823

5.  KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation.

Authors:  Nishi R Sharma; Vladimir Majerciak; Michael J Kruhlak; Zhi-Ming Zheng
Journal:  PLoS Pathog       Date:  2017-10-30       Impact factor: 6.823

Review 6.  From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.

Authors:  Vasiliki I Pantazopoulou; Stella Georgiou; Panos Kakoulidis; Stavroula N Giannakopoulou; Sofia Tseleni; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

Review 7.  AGO unchained: Canonical and non-canonical roles of Argonaute proteins in mammals.

Authors:  Laura Sala; Srividya Chandrasekhar; Joana A Vidigal
Journal:  Front Biosci (Landmark Ed)       Date:  2020-01-01

8.  The nuclear receptor ERβ engages AGO2 in regulation of gene transcription, RNA splicing and RISC loading.

Authors:  Roberta Tarallo; Giorgio Giurato; Giuseppina Bruno; Maria Ravo; Francesca Rizzo; Annamaria Salvati; Luca Ricciardi; Giovanna Marchese; Angela Cordella; Teresa Rocco; Valerio Gigantino; Biancamaria Pierri; Giovanni Cimmino; Luciano Milanesi; Concetta Ambrosino; Tuula A Nyman; Giovanni Nassa; Alessandro Weisz
Journal:  Genome Biol       Date:  2017-10-06       Impact factor: 13.583

Review 9.  Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.

Authors:  Hongyu Liu; Cheng Lei; Qin He; Zou Pan; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2018-02-22       Impact factor: 27.401

10.  Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.

Authors:  Ines Stevic; Volkmar Müller; Karsten Weber; Peter A Fasching; Thomas Karn; Frederic Marmé; Christian Schem; Elmar Stickeler; Carsten Denkert; Marion van Mackelenbergh; Christoph Salat; Andreas Schneeweiss; Klaus Pantel; Sibylle Loibl; Michael Untch; Heidi Schwarzenbach
Journal:  BMC Med       Date:  2018-10-10       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.